EZZ Life Science Valuation Multiples

EZZ Life Science is valued at $14M as of September 2026, a 0.1x revenue multiple. In the last 12 months, EZZ Life Science revenue was $33M.

EZZ Life Science Overview

About EZZ Life Science

EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.


Founded

2015

HQ

Australia

Employees

N/A

Financials (LTM)

Revenue: $33M
Net Income: ($4M)

EV

$4M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

EZZ Life Science Financials

EZZ Life Science reported last 12-month revenue of $33M.

In the same LTM period, EZZ Life Science generated had net loss of ($4M).

Revenue (LTM)


EZZ Life Science P&L

In the most recent fiscal year, EZZ Life Science reported revenue of $48M and EBITDA of $8M.

EZZ Life Science is profitable as of last fiscal year, with gross margin of 74%, EBITDA margin of 16%, and net margin of 10%.

See analyst estimates for EZZ Life Science
LTMLast FY202320242025202620272028
Revenue$33M$48M$37M$48M$40M
Gross Profit-$35M$29M$36M$36M
Gross Margin-74%77%76%88%
EBITDA-$8M$5M$7M$8M
EBITDA Margin-16%15%16%19%
EBIT Margin-15%14%15%18%
Net Profit($4M)$5M$4M$5M$486K
Net Margin(12%)10%10%10%1%
Net Debt-($15M)---

Financial data powered by Morningstar, Inc.

EZZ Life Science Stock Performance

EZZ Life Science has current market cap of $14M, and enterprise value of $4M.

Market Cap Evolution


EZZ Life Science's stock price is $0.29.

EZZ Life Science share price decreased by 30.5% in the last 30 days, and by 80.5% in the last year.

EZZ Life Science has an EPS (earnings per share) of $0.10.

See more trading valuation data for EZZ Life Science
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4M$14M-1.2%-30.5%16.1%-80.5%$0.10

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

EZZ Life Science Valuation Multiples

EZZ Life Science trades at 0.1x EV/Revenue multiple, and 0.6x EV/EBITDA.

See NTM and 2027E valuation multiples for EZZ Life Science

EV / Revenue (LTM)


EZZ Life Science Financial Valuation Multiples

As of September 19, 2026, EZZ Life Science has market cap of $14M and EV of $4M.

EZZ Life Science has a P/E ratio of (3.6x).

LTMLast FY202320242025202620272028
EV/Revenue0.1x0.1x0.1x0.1x0.1x
EV/EBITDA-0.6x0.8x0.6x0.5x
EV/EBIT-0.6x0.8x0.6x0.6x
EV/Gross Profit-0.1x0.1x0.1x0.1x
P/E(3.6x)2.9x3.6x2.8x28.2x
EV/FCF-1.4x1.2x1.2x(2.5x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified EZZ Life Science Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

EZZ Life Science Margins & Growth Rates

EZZ Life Science decreased revenue by 30% and net profit by 180% in the last fiscal year.

In the most recent fiscal year, EZZ Life Science reported gross margin of 74%, EBITDA margin of 16%, and net margin of 10%.

See estimated margins and future growth rates for EZZ Life Science

EZZ Life Science Margins

Last FY202420252026202720282029
Gross Margin74%76%88%-
EBITDA Margin16%16%19%-
EBIT Margin15%15%18%-
Net Margin10%10%1%(12%)
FCF Margin6%7%(4%)(19%)

EZZ Life Science Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(30%)29%(16%)(18%)
Gross Profit Growth-27%(1%)-
EBITDA Growth-37%3%-
EBIT Growth-37%1%-
Net Profit Growth(180%)29%(90%)(885%)
FCF Growth(312%)2%(148%)275%

Data powered by FactSet, Inc. and Morningstar, Inc.

EZZ Life Science Operational KPIs

Access forward-looking KPIs for EZZ Life Science
Last FY202320242025202620272028
S&M Expenses to Revenue48%56%52%57%
G&A Expenses to Revenue5%2%4%6%
Opex to Revenue59%63%61%71%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EZZ Life Science Competitors

EZZ Life Science competitors include McPherson's, Natural Health Trends, Read-Gene, CelLBxHealth, Biomerica, Lavena - Shumen, Cosma, Urteste, Big Tree Cloud Holdings and Inoviq.

Most EZZ Life Science public comparables operate across Diagnostics & Genomics, Health & Beauty, BioTech and DeepTech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
McPherson's$99M($9M)0.1x0.2x(1.6x)2.9x
Natural Health Trends$40M($458K)----
Read-Gene$4M$237K3.6x-62.2x-
CelLBxHealth$2M($21M)7.7x5.5x(0.7x)(1.3x)
Biomerica$4M($5M)2.8x-(2.7x)-
Lavena - Shumen$15M$2M0.7x-4.7x-
Cosma$4M($3M)3.6x-(6.4x)-
Urteste$6K($1M)2777.7x-(10.7x)-

This data is available for Pro users. Sign up to see all EZZ Life Science competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About EZZ Life Science

When was EZZ Life Science founded?EZZ Life Science was founded in 2015.
Where is EZZ Life Science headquartered?EZZ Life Science is headquartered in Australia.
Is EZZ Life Science publicly listed?Yes, EZZ Life Science is a public company listed on Australian Securities Exchange.
What is the stock symbol of EZZ Life Science?EZZ Life Science trades under EZZ ticker.
When did EZZ Life Science go public?EZZ Life Science went public in 2021.
Who are competitors of EZZ Life Science?EZZ Life Science main competitors include McPherson's, Natural Health Trends, Read-Gene, CelLBxHealth, Biomerica, Lavena - Shumen, Cosma, Urteste, Big Tree Cloud Holdings, Inoviq.
What is the current market cap of EZZ Life Science?EZZ Life Science's current market cap is $14M.
What is the current revenue of EZZ Life Science?EZZ Life Science's last 12 months revenue is $33M.
What is the current revenue growth of EZZ Life Science?EZZ Life Science revenue growth (vs. last FY) is (30%).
What is the current EV/Revenue multiple of EZZ Life Science?Current revenue multiple of EZZ Life Science is 0.1x.
Is EZZ Life Science profitable?No, EZZ Life Science is not profitable.
What is the current net income of EZZ Life Science?EZZ Life Science's last 12 months net income is ($4M).
How many companies EZZ Life Science has acquired to date?EZZ Life Science hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies EZZ Life Science has invested to date?EZZ Life Science hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to EZZ Life Science

Lists including EZZ Life Science

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial